- call +1-201-465-4211
- email sales@mrinsights.biz
Nanotechnology — the science of the extremely small — holds enormous potential for healthcare, from delivering drugs more effectively, diagnosing diseases more rapidly and sensitively, and delivering vaccines via aerosols and patches.Nanotechnology is the science of materials at the molecular or subatomic level. It involves manipulation of particles smaller than 100 nanometres (one nanometre is one-billionth of a metre) and the technology involves developing materials or devices within that size — invisible to the human eye and often many hundred times thinner than the width of human hair. The physics and chemistry of materials are radically different when reduced to the nanoscale; they have different strengths, conductivity and reactivity, and exploiting this could revolutionise medicine.
Scope of the Report:
This report studies the Healthcare Nanotechnology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare Nanotechnology market by product type and applications/end industries.
First of all，major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, it has drawback such as high costs of Nanotechnology-Based Medical Devices and it is money-consuming. Second, the United States dominates the market, and is expected to increase over the forecast period. In addition, Asia Pacific region is expected to witness highest growth rate over the forecast period owing to rapid population growth.
The global Healthcare Nanotechnology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare Nanotechnology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Teva Pharmaceuticals Industries
Johnson & Johnson
Pfizer
Merck
NanosphereInc
GE Healthcare Celgene Corporation
CombiMatrix Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Neurology
Cardiovascular
Oncology
Anti-inflammatory
Anti-infective
Market Segment by Applications, can be divided into
Drug Delivery System
Molecular Diagnostics
Clinical Oncology
Clinical Neurology
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Healthcare Nanotechnology Market Overview
1.1 Product Overview and Scope of Healthcare Nanotechnology
1.2 Classification of Healthcare Nanotechnology by Types
1.2.1 Global Healthcare Nanotechnology Revenue Comparison by Types (2017-2023)
1.2.2 Global Healthcare Nanotechnology Revenue Market Share by Types in 2017
1.2.3 Neurology
1.2.4 Cardiovascular
1.2.5 Oncology
1.2.6 Anti-inflammatory
1.2.7 Anti-infective
1.3 Global Healthcare Nanotechnology Market by Application
1.3.1 Global Healthcare Nanotechnology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Drug Delivery System
1.3.3 Molecular Diagnostics
1.3.4 Clinical Oncology
1.3.5 Clinical Neurology
1.4 Global Healthcare Nanotechnology Market by Regions
1.4.1 Global Healthcare Nanotechnology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Healthcare Nanotechnology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Healthcare Nanotechnology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare Nanotechnology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Healthcare Nanotechnology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare Nanotechnology Status and Prospect (2013-2023)
1.5 Global Market Size of Healthcare Nanotechnology (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Healthcare Nanotechnology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva Pharmaceuticals Industries
2.2.1 Business Overview
2.2.2 Healthcare Nanotechnology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Pharmaceuticals Industries Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Healthcare Nanotechnology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Healthcare Nanotechnology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Healthcare Nanotechnology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.6 NanosphereInc
2.6.1 Business Overview
2.6.2 Healthcare Nanotechnology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 NanosphereInc Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.7 GE Healthcare Celgene Corporation
2.7.1 Business Overview
2.7.2 Healthcare Nanotechnology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GE Healthcare Celgene Corporation Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
2.8 CombiMatrix Corporation
2.8.1 Business Overview
2.8.2 Healthcare Nanotechnology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CombiMatrix Corporation Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Healthcare Nanotechnology Market Competition, by Players
3.1 Global Healthcare Nanotechnology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Healthcare Nanotechnology Players Market Share
3.2.2 Top 10 Healthcare Nanotechnology Players Market Share
3.3 Market Competition Trend
4 Global Healthcare Nanotechnology Market Size by Regions
4.1 Global Healthcare Nanotechnology Revenue and Market Share by Regions
4.2 North America Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
4.3 Europe Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
4.5 South America Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
5 North America Healthcare Nanotechnology Revenue by Countries
5.1 North America Healthcare Nanotechnology Revenue by Countries (2013-2018)
5.2 USA Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
5.3 Canada Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
5.4 Mexico Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
6 Europe Healthcare Nanotechnology Revenue by Countries
6.1 Europe Healthcare Nanotechnology Revenue by Countries (2013-2018)
6.2 Germany Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
6.3 UK Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
6.4 France Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
6.5 Russia Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
6.6 Italy Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Healthcare Nanotechnology Revenue by Countries
7.1 Asia-Pacific Healthcare Nanotechnology Revenue by Countries (2013-2018)
7.2 China Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
7.3 Japan Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
7.4 Korea Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
7.5 India Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
8 South America Healthcare Nanotechnology Revenue by Countries
8.1 South America Healthcare Nanotechnology Revenue by Countries (2013-2018)
8.2 Brazil Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
8.3 Argentina Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
8.4 Colombia Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Healthcare Nanotechnology by Countries
9.1 Middle East and Africa Healthcare Nanotechnology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
9.3 UAE Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
9.4 Egypt Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
9.6 South Africa Healthcare Nanotechnology Revenue and Growth Rate (2013-2018)
10 Global Healthcare Nanotechnology Market Segment by Type
10.1 Global Healthcare Nanotechnology Revenue and Market Share by Type (2013-2018)
10.2 Global Healthcare Nanotechnology Market Forecast by Type (2018-2023)
10.3 Neurology Revenue Growth Rate (2013-2023)
10.4 Cardiovascular Revenue Growth Rate (2013-2023)
10.5 Oncology Revenue Growth Rate (2013-2023)
10.6 Anti-inflammatory Revenue Growth Rate (2013-2023)
10.7 Anti-infective Revenue Growth Rate (2013-2023)
11 Global Healthcare Nanotechnology Market Segment by Application
11.1 Global Healthcare Nanotechnology Revenue Market Share by Application (2013-2018)
11.2 Healthcare Nanotechnology Market Forecast by Application (2018-2023)
11.3 Drug Delivery System Revenue Growth (2013-2018)
11.4 Molecular Diagnostics Revenue Growth (2013-2018)
11.5 Clinical Oncology Revenue Growth (2013-2018)
11.6 Clinical Neurology Revenue Growth (2013-2018)
12 Global Healthcare Nanotechnology Market Size Forecast (2018-2023)
12.1 Global Healthcare Nanotechnology Market Size Forecast (2018-2023)
12.2 Global Healthcare Nanotechnology Market Forecast by Regions (2018-2023)
12.3 North America Healthcare Nanotechnology Revenue Market Forecast (2018-2023)
12.4 Europe Healthcare Nanotechnology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Healthcare Nanotechnology Revenue Market Forecast (2018-2023)
12.6 South America Healthcare Nanotechnology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Healthcare Nanotechnology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Healthcare Nanotechnology Picture
Table Product Specifications of Healthcare Nanotechnology
Table Global Healthcare Nanotechnology and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
